PPAR-gamma agonists as regulators of microglial activation and brain inflammation - PubMed (original) (raw)
Review
PPAR-gamma agonists as regulators of microglial activation and brain inflammation
Antonietta Bernardo et al. Curr Pharm Des. 2006.
Abstract
The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) belongs to a large group of nuclear receptors controlling reproduction, metabolism, development and immune response. Upon activation by specific agonists, these receptors form dimers and translocate to the nucleus, where they act as agonist-dependent transcription factors and regulate gene expression by binding to specific promoter regions of target genes. The observation that PPAR-gamma is involved in the regulation of macrophage differentiation and activation in the peripheral organs has prompted the investigation of the functional role of PPAR-gamma in microglial cells, the main macrophage population of the CNS. The present review summarizes the several lines of evidence supporting that PPAR-gamma natural and synthetic agonists may control brain inflammation by inhibiting several functions associated to microglial activation, such as the expression of surface antigens and the synthesis of nitric oxide, prostaglandins, inflammatory cytokines and chemokines. Moreover, one of the major natural PPAR-gamma agonist, 15d-prostaglandin J(2) may contribute to the safe elimination of activated microglia by inducing apoptosis. Synthetic PPAR-gamma agonists do not entirely reproduce the range of 15d-prostaglandin J(2) effects, suggesting that PPAR-gamma independent mechanisms are also involved in the action of this prostaglandin. In addition to microglia, PPAR-gamma agonists affect functions and survival of other neural cells, including astrocytes, oligodendrocytes and neurons. Although most of the evidence comes from in vitro observations, an increasing number of studies in animal models further supports the potential therapeutic use of PPAR-gamma agonists in human brain diseases including multiple sclerosis, Parkinson's disease and Alzheimer's disease.
Similar articles
- Hormone regulation of microglial cell activation: relevance to multiple sclerosis.
Drew PD, Storer PD, Xu J, Chavis JA. Drew PD, et al. Brain Res Brain Res Rev. 2005 Apr;48(2):322-7. doi: 10.1016/j.brainresrev.2004.12.020. Epub 2005 Jan 19. Brain Res Brain Res Rev. 2005. PMID: 15850670 Free PMC article. Review. - Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis.
Storer PD, Xu J, Chavis J, Drew PD. Storer PD, et al. J Neuroimmunol. 2005 Apr;161(1-2):113-22. doi: 10.1016/j.jneuroim.2004.12.015. J Neuroimmunol. 2005. PMID: 15748950 - 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
Phulwani NK, Feinstein DL, Gavrilyuk V, Akar C, Kielian T. Phulwani NK, et al. J Neurochem. 2006 Dec;99(5):1389-1402. doi: 10.1111/j.1471-4159.2006.04183.x. J Neurochem. 2006. PMID: 17074064 Free PMC article. - Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
Bernardo A, Ajmone-Cat MA, Gasparini L, Ongini E, Minghetti L. Bernardo A, et al. J Neurochem. 2005 Feb;92(4):895-903. doi: 10.1111/j.1471-4159.2004.02932.x. J Neurochem. 2005. PMID: 15686492 - Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.
Kapadia R, Yi JH, Vemuganti R. Kapadia R, et al. Front Biosci. 2008 Jan 1;13:1813-26. doi: 10.2741/2802. Front Biosci. 2008. PMID: 17981670 Free PMC article. Review.
Cited by
- Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.
Burgaz S, Navarro E, Rodríguez-Carreiro S, Navarrete C, Garrido-Rodríguez M, Lastres-Becker I, Chocarro J, Lanciego JL, Muñoz E, Fernández-Ruiz J. Burgaz S, et al. Behav Brain Funct. 2024 Nov 1;20(1):28. doi: 10.1186/s12993-024-00256-9. Behav Brain Funct. 2024. PMID: 39487447 Free PMC article. - Chronic Low-Dose Alcohol Consumption Attenuates Post-Ischemic Inflammation via PPARγ in Mice.
Li C, Li J, Loreno EG, Miriyala S, Panchatcharam M, Lu X, Sun H. Li C, et al. Int J Mol Sci. 2021 May 12;22(10):5121. doi: 10.3390/ijms22105121. Int J Mol Sci. 2021. PMID: 34066125 Free PMC article. - Two Rationally Identified Novel Glitazones Reversed the Behavioral Dysfunctions and Exhibited Neuroprotection Through Ameliorating Brain Cytokines and Oxy-Radicals in ICV-LPS Neuroinflammatory Rat Model.
Justin A, Ashwini P, Jose JA, Jeyarani V, Dhanabal SP, Manisha C, Mandal SP, Bhavimani G, Prabitha P, Yuvaraj S, Prashantha Kumar BR. Justin A, et al. Front Neurosci. 2020 Sep 25;14:530148. doi: 10.3389/fnins.2020.530148. eCollection 2020. Front Neurosci. 2020. PMID: 33100954 Free PMC article. - PPARs and molecular mechanisms of transrepression.
Ricote M, Glass CK. Ricote M, et al. Biochim Biophys Acta. 2007 Aug;1771(8):926-35. doi: 10.1016/j.bbalip.2007.02.013. Epub 2007 Mar 12. Biochim Biophys Acta. 2007. PMID: 17433773 Free PMC article. Review. - Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease.
Randy LH, Guoying B. Randy LH, et al. Curr Neuropharmacol. 2007 Mar;5(1):35-46. doi: 10.2174/157015907780077123. Curr Neuropharmacol. 2007. PMID: 18615152 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical